nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer
|
Han, Hye-Suk |
|
2008 |
115 |
2 |
p. 335-342 |
artikel |
2 |
A retrospective study of quality of life in a community sample of patients with early stage breast cancer
|
Walker, Mark S. |
|
2009 |
115 |
2 |
p. 415-422 |
artikel |
3 |
Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy
|
Yang, Qifeng |
|
2008 |
115 |
2 |
p. 343-348 |
artikel |
4 |
BRCA1 promoter methylation is associated with increased mortality among women with breast cancer
|
Xu, Xinran |
|
2008 |
115 |
2 |
p. 397-404 |
artikel |
5 |
Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse model
|
Zhou, Jiangbing |
|
2008 |
115 |
2 |
p. 269-277 |
artikel |
6 |
Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients
|
Yin, Wen-Jin |
|
2008 |
115 |
2 |
p. 325-333 |
artikel |
7 |
Cost-effective analyses in Breast Cancer Research and Treatment
|
Lippman, Marc E. |
|
2009 |
115 |
2 |
p. 221-222 |
artikel |
8 |
CYP2C19*17 is associated with decreased breast cancer risk
|
Justenhoven, Christina |
|
2008 |
115 |
2 |
p. 391-396 |
artikel |
9 |
Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?
|
Jacobi, Catharina E. |
|
2008 |
115 |
2 |
p. 381-390 |
artikel |
10 |
Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer
|
Çam, Ragip |
|
2008 |
115 |
2 |
p. 431-432 |
artikel |
11 |
Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic review
|
Flemming, Jennifer |
|
2008 |
115 |
2 |
p. 255-268 |
artikel |
12 |
High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations
|
Juan, Inmaculada de |
|
2008 |
115 |
2 |
p. 405-414 |
artikel |
13 |
Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells
|
Lanzino, Marilena |
|
2008 |
115 |
2 |
p. 297-306 |
artikel |
14 |
Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families
|
Hansen, Thomas v. O. |
|
2008 |
115 |
2 |
p. 315-323 |
artikel |
15 |
Link between insulin and metabolic disorders in cancer: does leptin play a key role?
|
Malandrino, Noemi |
|
2008 |
115 |
2 |
p. 435-436 |
artikel |
16 |
No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers
|
Spurdle, Amanda B. |
|
2008 |
115 |
2 |
p. 307-313 |
artikel |
17 |
Pattern of metastatic spread in triple-negative breast cancer
|
Dent, Rebecca |
|
2008 |
115 |
2 |
p. 423-428 |
artikel |
18 |
Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers
|
Baak, Jan P. A. |
|
2008 |
115 |
2 |
p. 241-254 |
artikel |
19 |
Psychological impact of recall in high-risk breast MRI screening
|
O’Neill, Suzanne M. |
|
2008 |
115 |
2 |
p. 365-371 |
artikel |
20 |
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
|
Byrski, T. |
|
2008 |
115 |
2 |
p. 359-363 |
artikel |
21 |
Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors
|
Brouckaert, Olivier |
|
2008 |
115 |
2 |
p. 349-358 |
artikel |
22 |
Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones
|
Potter, Shirley M. |
|
2008 |
115 |
2 |
p. 279-287 |
artikel |
23 |
Terpenoids and breast cancer chemoprevention
|
Rabi, Thangaiyan |
|
2008 |
115 |
2 |
p. 223-239 |
artikel |
24 |
The androgen metabolite 5α-androstane-3β,17β-diol (3βAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance
|
Sikora, Matthew J. |
|
2008 |
115 |
2 |
p. 289-296 |
artikel |
25 |
The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer
|
Bartsch, Rupert |
|
2008 |
115 |
2 |
p. 373-380 |
artikel |
26 |
The rising incidence of male breast cancer
|
Speirs, Valerie |
|
2008 |
115 |
2 |
p. 429-430 |
artikel |
27 |
The sensitivity of BRCA1 mutation carriers to ionising radiation: questions of methodology
|
Chechlinska, Magdalena |
|
2008 |
115 |
2 |
p. 433 |
artikel |